Successful osimertinib rechallenge after osimertinib-induced pneumonitis in a patient with lung adenocarcinoma

Pneumonitis is a serious adverse event of EGFR-TKI treatment. Although several cases of EGFR-TKI rechallenge after EGFR-TKI-induced pneumonitis have been reported, little is known about post-pneumonitis osimertinib rechallenge. We describe a 69-year-old never-smoking Japanese woman with postoperativ...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Respir Med Case Rep
Main Authors: Satoh, Shingo, Shiroyama, Takayuki, Tamiya, Motohiro, Nasu, Shingo, Tanaka, Ayako, Morita, Satomu, Morishita, Naoko, Suzuki, Hidekazu, Okamoto, Norio, Hirashima, Tomonori
Format: Artigo
Sprog:Inglês
Udgivet: Elsevier 2017
Fag:
Case Report
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5805846/
https://ncbi.nlm.nih.gov/pubmed/29487786
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.rmcr.2017.12.005
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker